Incidence of VTE and bleeding among hospitalized patients with coronavirus disease 2019: a systematic review and meta-analysis
Background Individual studies have reported widely variable rates for VTE and bleeding
among hospitalized patients with coronavirus disease 2019 (COVID-19). Research Question …
among hospitalized patients with coronavirus disease 2019 (COVID-19). Research Question …
[HTML][HTML] Risk of venous thromboembolism in patients with COVID‐19: a systematic review and meta‐analysis
Background Venous thromboembolism (VTE) is frequently observed in patients with
coronavirus disease 2019 (COVID‐19). However, reported VTE rates differ substantially …
coronavirus disease 2019 (COVID‐19). However, reported VTE rates differ substantially …
C-reactive protein and clinical outcomes in patients with COVID-19
NR Smilowitz, D Kunichoff, M Garshick… - European heart …, 2021 - academic.oup.com
Background A systemic inflammatory response is observed in coronavirus disease 2019
(COVID-19). Elevated serum levels of C-reactive protein (CRP), a marker of systemic …
(COVID-19). Elevated serum levels of C-reactive protein (CRP), a marker of systemic …
Arterial and venous thromboembolism in COVID-19: a study-level meta-analysis
BK Tan, S Mainbourg, A Friggeri, L Bertoletti… - Thorax, 2021 - thorax.bmj.com
Background The prevalence of venous thromboembolic event (VTE) and arterial
thromboembolic event (ATE) thromboembolic events in patients with COVID-19 remains …
thromboembolic event (ATE) thromboembolic events in patients with COVID-19 remains …
Venous thromboembolism in COVID-19: A systematic review and meta-analysis
A Kollias, KG Kyriakoulis, S Lagou… - Vascular …, 2021 - journals.sagepub.com
Severe coronavirus disease 2019 (COVID-19) is associated with increased risk of venous
thromboembolism events (VTE). This study performed a systematic review in …
thromboembolism events (VTE). This study performed a systematic review in …
Heart failure in COVID‐19 patients: prevalence, incidence and prognostic implications
JR Rey, J Caro‐Codón, SO Rosillo… - European journal of …, 2020 - Wiley Online Library
Aims Data on the impact of COVID‐19 in chronic heart failure (CHF) patients and its
potential to trigger acute heart failure (AHF) are lacking. The aim of this work was to study …
potential to trigger acute heart failure (AHF) are lacking. The aim of this work was to study …
[HTML][HTML] Cardiovascular manifestations of COVID-19 infection
SARS-CoV-2 induced the novel coronavirus disease (COVID-19) outbreak, the most
significant medical challenge in the last century. COVID-19 is associated with notable …
significant medical challenge in the last century. COVID-19 is associated with notable …
ESC guidance for the diagnosis and management of cardiovascular disease during the COVID-19 pandemic: part 2—care pathways, treatment, and follow-up
Cardiovascular Research, 2022 - academic.oup.com
Aims Since its emergence in early 2020, the novel severe acute respiratory syndrome
coronavirus 2 causing coronavirus disease 2019 (COVID-19) has reached pandemic levels …
coronavirus 2 causing coronavirus disease 2019 (COVID-19) has reached pandemic levels …
[HTML][HTML] Comparison of the characteristics, morbidity, and mortality of COVID-19 and seasonal influenza: a nationwide, population-based retrospective cohort study
L Piroth, J Cottenet, AS Mariet, P Bonniaud… - The Lancet …, 2021 - thelancet.com
Background To date, influenza epidemics have been considered suitable for use as a model
for the COVID-19 epidemic, given that they are respiratory diseases with similar modes of …
for the COVID-19 epidemic, given that they are respiratory diseases with similar modes of …
Incidence of acute pulmonary embolism in COVID-19 patients: Systematic review and meta-analysis.
Background Acute pulmonary embolism (PE) has been described as a frequent and
prognostically relevant complication of COVID-19 infection. Aim We performed a systematic …
prognostically relevant complication of COVID-19 infection. Aim We performed a systematic …